GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers

<p>Abstract</p> <p>Background</p> <p>Increased glycolytic activity is a hallmark of cancer, allowing staging and restaging with <sup>18</sup>F-fluorodeoxyglucose-positron-emission-tomography (PET). Since interim-PET is an important prognostic tool in Hodgkin...

Full description

Bibliographic Details
Main Authors: Hartmann Sylvia, Agostinelli Claudio, Diener Jürgen, Döring Claudia, Fanti Stefano, Zinzani Pier, Gallamini Andrea, Bergmann Lothar, Pileri Stefano, Hansmann Martin-Leo
Format: Article
Language:English
Published: BMC 2012-12-01
Series:BMC Cancer
Subjects:
Online Access:http://www.biomedcentral.com/1471-2407/12/586
_version_ 1818569604834787328
author Hartmann Sylvia
Agostinelli Claudio
Diener Jürgen
Döring Claudia
Fanti Stefano
Zinzani Pier
Gallamini Andrea
Bergmann Lothar
Pileri Stefano
Hansmann Martin-Leo
author_facet Hartmann Sylvia
Agostinelli Claudio
Diener Jürgen
Döring Claudia
Fanti Stefano
Zinzani Pier
Gallamini Andrea
Bergmann Lothar
Pileri Stefano
Hansmann Martin-Leo
author_sort Hartmann Sylvia
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Increased glycolytic activity is a hallmark of cancer, allowing staging and restaging with <sup>18</sup>F-fluorodeoxyglucose-positron-emission-tomography (PET). Since interim-PET is an important prognostic tool in Hodgkin lymphoma (HL), the aim of this study was to investigate the expression of proteins involved in the regulation of glucose metabolism in the different HL subtypes and their impact on clinical outcome.</p> <p>Methods</p> <p>Lymph node biopsies from 54 HL cases and reactive lymphoid tissue were stained for glucose transporter 1 (GLUT1), lactate dehydrogenase A (LDHA) and lactate exporter proteins MCT1 and MCT4. In a second series, samples from additional 153 HL cases with available clinical data were stained for GLUT1 and LDHA.</p> <p>Results</p> <p>Membrane bound GLUT1 expression was frequently observed in the tumor cells of HL (49% of all cases) but showed a broad variety between the different Hodgkin lymphoma subtypes: Nodular sclerosing HL subtype displayed a membrane bound GLUT1 expression in the Hodgkin-and Reed-Sternberg cells in 56% of the cases. However, membrane bound GLUT1 expression was more rarely observed in tumor cells of lymphocyte rich classical HL subtype (30%) or nodular lymphocyte predominant HL subtype (15%). Interestingly, in both of these lymphocyte rich HL subtypes as well as in progressively transformed germinal centers, reactive B cells displayed strong expression of GLUT1. LDHA, acting downstream of glycolysis, was also expressed in 44% of all cases. We evaluated the prognostic value of different GLUT1 and LDHA expression patterns; however, no significant differences in progression free or overall survival were found between patients exhibiting different GLUT1 or LDHA expression patterns. There was no correlation between GLUT1 expression in HRS cells and PET standard uptake values.</p> <p>Conclusions</p> <p>In a large number of cases, HRS cells in classical HL express high levels of GLUT1 and LDHA indicating glycolytic activity in the tumor cells. Although interim-PET is an important prognostic tool, a predictive value of GLUT1 or LDHA staining of the primary diagnostic biopsy could not be demonstrated. However, we observed GLUT1 expression in progressively transformed germinal centers and hyperplastic follicles, explaining false positive results in PET. Therefore, PET findings suggestive of HL relapse should always be confirmed by histology.</p>
first_indexed 2024-12-14T06:50:07Z
format Article
id doaj.art-efad1b96c60b455bbd1b9c271ca8cb19
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-14T06:50:07Z
publishDate 2012-12-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-efad1b96c60b455bbd1b9c271ca8cb192022-12-21T23:12:55ZengBMCBMC Cancer1471-24072012-12-0112158610.1186/1471-2407-12-586GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centersHartmann SylviaAgostinelli ClaudioDiener JürgenDöring ClaudiaFanti StefanoZinzani PierGallamini AndreaBergmann LotharPileri StefanoHansmann Martin-Leo<p>Abstract</p> <p>Background</p> <p>Increased glycolytic activity is a hallmark of cancer, allowing staging and restaging with <sup>18</sup>F-fluorodeoxyglucose-positron-emission-tomography (PET). Since interim-PET is an important prognostic tool in Hodgkin lymphoma (HL), the aim of this study was to investigate the expression of proteins involved in the regulation of glucose metabolism in the different HL subtypes and their impact on clinical outcome.</p> <p>Methods</p> <p>Lymph node biopsies from 54 HL cases and reactive lymphoid tissue were stained for glucose transporter 1 (GLUT1), lactate dehydrogenase A (LDHA) and lactate exporter proteins MCT1 and MCT4. In a second series, samples from additional 153 HL cases with available clinical data were stained for GLUT1 and LDHA.</p> <p>Results</p> <p>Membrane bound GLUT1 expression was frequently observed in the tumor cells of HL (49% of all cases) but showed a broad variety between the different Hodgkin lymphoma subtypes: Nodular sclerosing HL subtype displayed a membrane bound GLUT1 expression in the Hodgkin-and Reed-Sternberg cells in 56% of the cases. However, membrane bound GLUT1 expression was more rarely observed in tumor cells of lymphocyte rich classical HL subtype (30%) or nodular lymphocyte predominant HL subtype (15%). Interestingly, in both of these lymphocyte rich HL subtypes as well as in progressively transformed germinal centers, reactive B cells displayed strong expression of GLUT1. LDHA, acting downstream of glycolysis, was also expressed in 44% of all cases. We evaluated the prognostic value of different GLUT1 and LDHA expression patterns; however, no significant differences in progression free or overall survival were found between patients exhibiting different GLUT1 or LDHA expression patterns. There was no correlation between GLUT1 expression in HRS cells and PET standard uptake values.</p> <p>Conclusions</p> <p>In a large number of cases, HRS cells in classical HL express high levels of GLUT1 and LDHA indicating glycolytic activity in the tumor cells. Although interim-PET is an important prognostic tool, a predictive value of GLUT1 or LDHA staining of the primary diagnostic biopsy could not be demonstrated. However, we observed GLUT1 expression in progressively transformed germinal centers and hyperplastic follicles, explaining false positive results in PET. Therefore, PET findings suggestive of HL relapse should always be confirmed by histology.</p>http://www.biomedcentral.com/1471-2407/12/586Hodgkin lymphomaGLUT1GlycolysisWarburg effect
spellingShingle Hartmann Sylvia
Agostinelli Claudio
Diener Jürgen
Döring Claudia
Fanti Stefano
Zinzani Pier
Gallamini Andrea
Bergmann Lothar
Pileri Stefano
Hansmann Martin-Leo
GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers
BMC Cancer
Hodgkin lymphoma
GLUT1
Glycolysis
Warburg effect
title GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers
title_full GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers
title_fullStr GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers
title_full_unstemmed GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers
title_short GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers
title_sort glut1 expression patterns in different hodgkin lymphoma subtypes and progressively transformed germinal centers
topic Hodgkin lymphoma
GLUT1
Glycolysis
Warburg effect
url http://www.biomedcentral.com/1471-2407/12/586
work_keys_str_mv AT hartmannsylvia glut1expressionpatternsindifferenthodgkinlymphomasubtypesandprogressivelytransformedgerminalcenters
AT agostinelliclaudio glut1expressionpatternsindifferenthodgkinlymphomasubtypesandprogressivelytransformedgerminalcenters
AT dienerjurgen glut1expressionpatternsindifferenthodgkinlymphomasubtypesandprogressivelytransformedgerminalcenters
AT doringclaudia glut1expressionpatternsindifferenthodgkinlymphomasubtypesandprogressivelytransformedgerminalcenters
AT fantistefano glut1expressionpatternsindifferenthodgkinlymphomasubtypesandprogressivelytransformedgerminalcenters
AT zinzanipier glut1expressionpatternsindifferenthodgkinlymphomasubtypesandprogressivelytransformedgerminalcenters
AT gallaminiandrea glut1expressionpatternsindifferenthodgkinlymphomasubtypesandprogressivelytransformedgerminalcenters
AT bergmannlothar glut1expressionpatternsindifferenthodgkinlymphomasubtypesandprogressivelytransformedgerminalcenters
AT pileristefano glut1expressionpatternsindifferenthodgkinlymphomasubtypesandprogressivelytransformedgerminalcenters
AT hansmannmartinleo glut1expressionpatternsindifferenthodgkinlymphomasubtypesandprogressivelytransformedgerminalcenters